Hansa Medical AB (publ) today announced the acquisition of UK based Immago Biosystems Ltd, a University of Oxford-spinout focused on the enhancement of antibody based cancer therapies using antibody-modulating enzymes. The founders of Immago Biosystems, Dr Chris Scanlan and Dr Max Crispin at the Glycoprotein Therapeutics Laboratory, at the University of Oxford, have discovered that IgG-antibody modulating enzymes can enhance the efficacy of antibody based cancer treatments. Together with their colleague, Dr Kavitha Baruah, they formed Immago Biosystems Ltd to help bring these concepts to the clinic. Immago Biosystems has applied for patent protection for this concept, and the research results have subsequently been published in the Journal of Molecular Biology, 2012 Jun 29;420(1-2):1-7. Hansa Medical has recently verified the research findings by combining its lead candidate IdeS with approved anti-cancer antibodies in preclinical cancer models, and has applied for further patent protection in this area. “By combining IdeS with a therapeutic antibody, the in vitro and in vivo efficacy of the antibody is significantly enhanced with maintained specificity. Potentially, this means that presently available antibody based cancer therapies could be made more effective”, commented Dr Christian Kjellman, Senior Vice President, R&D at Hansa Medical AB. “Our verification of the research findings by Immago has encouraged us to further examine the potential of IdeS and EndoS within cancer immunotherapy. Although the findings are to be regarded as early preclinical research findings, we believe that this concept can hold significant potential for IdeS and EndoS in addition to the focus of our current clinical program in transplantation and autoimmunity,” said Göran Arvidson, CEO of Hansa Medical AB. The global market for monoclonal antibodies (mAbs) for cancer is estimated at $23 billion, and is expected to grow to $33 billion by 2017, according to Cancer Monoclonal Antibodies Market Forecast to 2017 (August 13, 2013). The sum of the acquisition was not disclosed. The acquisition will not have a significant impact on the Hansa Medical result for 2016. The information in this press release is disclosed pursuant to the EU Market Abuse Regulation. The information was released for public disclosure through the agency of the contact person stated below on July 19, 2016 at 13.00 CET. For further information, please contact: Hansa Medical AB Göran Arvidson, CEO Mobile: 46 70-633 30 42 E-mail: goran.arvidson@hansamedical.com www.hansamedical.com About the antibody enhancement technology by Immago Biosystems Many antibody based cancer therapies rely on activation of the immune system via so called Antibody Dependent Cell mediated Cytotoxicity (ADCC). These antibodies bind to antigens on cancer cells and once attached, the antibody attracts immune cells via the Fc-gamma receptors on the surface of cytotoxic immune cells, which then destroy the cancer cells. At physiological conditions, the majority of Fc -gamma receptors are bound to naturally occurring antibodies from the plasma, so activation of immune cells by a therapeutic antibody is dependent upon the displacement of irrelevant plasma antibodies prior to binding. Pretreatment with IdeS or EndoS prior to treatment with an antibody based cancer therapy, displaces the irrelevant antibodies, leaving room for the therapeutic antibodies to bind to Fc-gamma receptors on the surface of immune cells. This results in cytotoxic immune cells with a significantly higher load of therapeutic antibodies directed towards cancer cells. For more information, please visit www.hansamedical.com/antibodyenhancement About Immago Biosystems Ltd. Immago Biosystems Ltd was founded in 2013 from research arising in the Oxford Glycobiology Institute within the Department of Biochemistry at the University of Oxford. Dr Chris Scanlan and Dr Max Crispin invented ‘receptor refocusing’ which aims to enhances immune-mediated killing of cancer cells by modulating the endogenous antibody repertoire with enzymes such as IdeS and EndoS. Together with their colleague, Dr Kavitha Baruah, they formed Immago Biosystems Ltd to help bring these concepts to the clinic. About Dr Chris Scanlan Dr Chris Scanlan was a group leader in the Oxford Glycobiology Institute at the University of Oxford, and held lectureships at Corpus Christi College and Oriel College, Oxford. Dr Scanlan died from cancer in 2013, aged just 35. Dr Scanlan made seminal contributions to immunology and the global effort to develop an HIV vaccine, with one of his key papers attracting over 650 citations. His later work focused on biotherapeutics against cancer. It was this work, with Dr Max Crispin, that led to the founding of Immago Biosytems. About Dr Max Crispin Dr Max Crispin runs the Glycoprotein Therapeutics Laboratory within the Oxford Glycobiology Institute at the University of Oxford. Dr Max Crispin has published over 70 papers in the fields of glycobiology, immunology and virology. He holds the Against Breast Cancer Fellowship at Oriel College, Oxford, which was awarded for his work on immunotherapeutics (www.againstbreastcancer.org.uk). He is a Lecturer in Biochemistry at Corpus Christi College, Oxford. Email: max.crispin@bioch.ox.ac.uk. About Hansa Medical AB Hansa Medical is a biopharmaceutical company focusing on novel immunomodulatory enzymes. The lead project IdeS is an antibody-degrading enzyme in clinical development, with potential use in transplantation and rare autoimmune diseases. Additional projects focus on development of new antibody modulating enzymes, as well as HBP, a diagnostic biomarker for prediction of severe sepsis at emergency departments that is already introduced on the market. The company is based in Lund, Sweden. Hansa Medical’s share (ticker: HMED) is listed on Nasdaq Stockholm.
Hansa Medical acquires rights to cancer immunotherapy using
Top 10 Most Recent News Articles
Adcendo’s Early Sarcoma Data Earns a Careful Look
Sarcoma data rarely gives anyone permission to pound the table, yet Adcendo’s first look at ADCE-D01 deserves more than a polite nod. In advanced soft tissue sarcoma, where patients have often run through the usual options and second-line response rates historically sit around 4% to 10%, a reported 30% objective response rate on the every-two-week schedule is...
Continue Reading
BetterInvesting Puts ELMD and FIVE Under a Fresh Lens
Two familiar market traps are hiding in this otherwise useful announcement: mistaking a study candidate for a buy signal, and treating the word undervalued like it fell from a mountaintop. BetterInvesting has named Electromed Inc. as its “Stock to Study” and Five Below Inc. as its “Undervalued Stock” for the January-February 2027 issue of its magazine. That is...
Continue Reading
GFT's Banking Leader Tag Puts Execution Risks Into Focus
A banking overhaul is where glossy slides go to die. That is why GFT Technologies being named a Leader in QKS Group's 2026 SPARK Matrix for Digital Banking Services deserves a little more attention than the usual analyst-firm trumpet blast. This is not a prize for making a pretty mobile app. The work described here runs through strategy, architecture, core-platform...
Continue Reading
Vision Marine's Cash Cleanup Meets a Hard Reality Ahead
A boat dealer slashing debt by $27.5 million deserves a nod, even when the rest of the ledger still makes your eyebrows climb. Vision Marine Technologies turned fiscal 2026 into a working-capital cleanup job: inventory came down hard, floor-plan financing nearly vanished, and operating cash flow finally turned positive. For NASDAQ:VMAR, that is real progress. It is not,...
Continue Reading
American Pride Bank Tests a Fast Southeast Expansion
Those old Winston-Salem smokestacks make a fitting backdrop for a bank trying to build something new, and American Pride Bank is moving with uncommon speed. Its new office at 450 N. Patterson Ave., Suite 200 sits in the Bailey South building in Innovation Quarter, across from Bailey Park and amid a district deliberately remade for founders, researchers and growing...
Continue Reading
Housing's Value Equation Is Getting More Complicated
A homeowner's insurance bill has become a louder market signal than a granite countertop. Green Builder Media's latest batch of research, publishing and events is aimed squarely at that uncomfortable truth: housing is no longer judged only by the price on the contract. Buyers, builders, lenders and insurers are being pushed to reckon with what a home costs to own, protect...
Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus
A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...
Continue Reading
EmTech AI 2027 Puts AI Ambitions Through Reality Test
A three-day gathering cannot settle AI's biggest arguments, but MIT Technology Review has picked the right fight for EmTech AI 2027: make the industry face a Reality Test. The conference runs May 11–13, 2027, at MIT's campus and online, and that theme lands because the AI conversation has spent plenty of time admiring the engine while skipping the ugly maintenance bill....
Continue Reading
Miami I20 Tests Appetite for Long-Term U.S. Capital
Five days in a Miami airport hotel may not sound like the machinery of national investment policy, yet the guest list for the inaugural I20 Summit is serious enough to make capital markets sit up. From December 11 through 15, the Sovereign Wealth Fund Institute plans to bring sovereign funds, pensions, endowments, family offices, business leaders and U.S....
Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth
Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...
Continue ReadingTop 5 Most Recently Viewed Articles
AXIA Time Launches New College Football Playoff Limited Edition
Introducing AXIA Time's New College Football Playoff Collection AXIA Time is making waves with its expanded partnership with the College Football Playoff (CFP) and the launch of a fantastic new collection. Known for its high-quality craftsmanship, AXIA Time has introduced a series of limited edition, heirloom-quality watches specifically created for the 2025 College...
Continue Reading
Uphold Launches Staking Services for UK Users Amid Changes
Uphold Introduces Staking Features for UK Customers Customers of Uphold can now take advantage of staking rewards on their crypto assets. This major shift comes after the UK Treasury amended the Financial Services and Markets Act, allowing crypto-asset service providers to offer staking services to individuals and businesses within the United Kingdom. Impact of Regulatory...
Continue Reading
ASDS Annual Conference: Elevating Dermatology Education for 2025
Registration Now Open for 2025 ASDS Annual Conference The American Society for Dermatologic Surgery (ASDS) has announced the opening of registration for its highly anticipated annual meeting. This prestigious event gathers dermatologists and their staff for a four-day immersive experience aimed at improving skills and knowledge in dermatologic surgery. The conference will...
Continue Reading
Revolutionizing Order Management with OMS+ Cloud Solution
DataXstream Unveils OMS+ Cloud Solution for Enhanced Order Management DataXstream LLC has rolled out its latest innovation, the OMS+ Cloud specifically designed for SAP S/4HANA Cloud Public Edition, aiming to transform how businesses manage their sales and order processes. Transforming Sales and Order Processes For more than a decade, OMS+ has been at the forefront of...
Continue Reading
Innovative Paper Towel Stand Redefines Hygiene and Convenience
Revolutionary Design for Paper Towel Dispensing In a world where hygiene is paramount, a visionary inventor from Oakgrove has developed an innovative solution known as the Adjustable Paper Towel Stand. This unique accessory is designed to dispense paper towels one at a time, effectively minimizing contact with the entire roll, which can often lead to contamination and...
Continue Reading